Drug Profile
TD 2749
Latest Information Update: 23 Nov 2016
Price :
$50
*
At a glance
- Originator Theravance
- Class Gastrokinetics; Irritable bowel syndrome therapies
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastrointestinal disorders